The FDA has warned that ketamine and compounded ketamine products aren’t approved to deal with any psychiatric disorder. This indicates that they haven’t been proven to get Secure or effective. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but only https://asenacav122uky0.blogdosaga.com/profile